Abstract:Background: Major depressive disorder (MDD) is a severe mental illness that affects more than 350 million people worldwide. However, the molecular mechanisms of depression are currently unclear. Studies suggest that Drosophila and humans have similar depression-like symptoms under pressure. In this research, we choose Drosophila melanogaster as the animal model to explore the molecular mechanisms that trigger depression. Results: We found that feeding D. melanogaster with the medium containing Levodopa or Chlorpromazine could induce depression-like phenotypes in both behavioral and biochemical biomarkers, including significantly decreased food intake, mating frequency, serotonin (5-HT) concentration, and increased malondialdehyde (MDA) concentration as well as reduced activity of superoxide dismutase (SOD). Moreover, the progeny of Chlorpromazine-treated flies also showed these depression-like features. By RNA-seq technology, we identified 467 genes that were differentially expressed between Chlorpromazine treated (CPZ) and control male flies [fold-change of ≥2 (q-value<5%)]. When comparing CPZ with control flies, 312 genes were upregulated and 155 genes downregulated. Differential expression of genes related to metabolic pathway, Parkinson's disease, Huntington's disease, Alzheimer's disease and lysozyme pathways were observed. Quantitative reverse transcriptase PCR (qRT-PCR) confirmed that 19 genes are differentially expressed in CPZ and control male flies. Conclusions: Levodopa, or Chlorpromazine can induce depression-like phenotypes in D. melanogaster regarding changes of appetite and sexual activity, and some key biochemical markers. A total of 467 genes were identified by RNA-seq analysis to have at least a 2-fold-change in expression between CPZ and control flies, including genes involved in metabolism, neurological diseases and lysozyme pathways. Our data provide additional insight into molecular mechanisms underlying depressive disorders in humans and may also contribute to clinical treatment.

5-HT stimulation of heart rate in Drosophila does not act through cAMP as revealed by pharmacogenetics

Modulation of the cardiac pacemaker of Drosophila: cellular mechanisms

Pharmacological identification of cholinergic receptor subtypes on Drosophila melanogaster larval heart

Aging and CaMKII alter intracellular Ca2+ transients and heart rhythm in Drosophila melanogaster

Mechanical and Chemical Factors Required for Maintaining Cardiac Rhythm in Drosophila melanogaster Larva

Effects of population structure and sex on association between serotonin receptors and Drosophila heart rate

A New Drosophila Octopamine Receptor Responds to Serotonin.

Arrhythmia caused by a Drosophila tropomyosin mutation is revealed using a novel optical coherence tomography instrument

Myotropic effects of FMRFamide containing peptides on the heart of the mosquito Anopheles gambiae

Conservation of cardiac L-type Ca2+ channels and their regulation in Drosophila: A novel genetically-pliable channelopathic model

Serotonin receptor 5-HT7 in Drosophila mushroom body neurons mediates larval appetitive olfactory learning

Smoking flies: testing the effect of tobacco cigarettes on heart function of Drosophila melanogaster

KCNQ potassium channel mutations cause cardiac arrhythmias in Drosophila that mimic the effects of aging

Transcriptional changes in specific subsets of Drosophila neurons following inhibition of the serotonin transporter

Drug discovery through functional screening in the Drosophila heart

Octopamine mediates sugar relief from a chronic-stress-induced depression-like state in Drosophila

Cardioacceleratory function of the neurohormone CCAP in the mosquito Anopheles gambiae

Serotonergic control of feeding microstructure in Drosophila

Age-associated cardiac dysfunction in Drosophila melanogaster

Modulation of dihydropyridine-sensitive calcium channels in Drosophila by a cAMP-mediated pathway

Drug induces depression-like phenotypes and alters gene expression profiles in Drosophila